Relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) in a French teaching hospital
Open Access
- 1 September 2003
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 52 (9) , 801-806
- https://doi.org/10.1099/jmm.0.05252-0
Abstract
The objective of this study was to investigate the relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) over a period of 4 years. The antibiotype of all MRSA isolates that were identified during a yearly period of 3 months was determined; 50 consecutive non-replicate MRSA isolates were typed each year. Susceptibility rates to gentamicin, tobramycin and ofloxacin remained stable (95, 16 and 4 %, respectively). In contrast, the proportion of MRSA isolates susceptible to erythromycin increased progressively from 10.5 to 32.5 % (P < 0.001). PFGE analysis of genomic DNA from 200 isolates revealed the presence of 15 different clones. Two epidemic clones were identified, which contained 150 (clone A) and 28 (clone C) isolates. Non-epidemic strains were more frequently susceptible to ofloxacin (31.8 versus 1.1 %) and tobramycin (45.4 versus 16.8 %) than epidemic strains; those isolates that were susceptible to all antibiotics tested belonged to sporadic clones. The increase of erythromycin susceptibility within MRSA isolates was caused by the emergence of clone C. This study suggests that when selection pressure exerted by an antibiotic is insufficient (i.e. below a threshold level), fitness advantages play a predominant role in the dissemination of MRSA clones. The balance between the selection pressure exerted by antibiotics and the disadvantage of lower replication rates of resistant strains in the absence of antibiotics complicates the biological model of clonal dissemination of epidemic MRSA strains.Keywords
This publication has 16 references indexed in Scilit:
- Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBLE) in Northern France: a five-year multicentre incidence studyJournal of Hospital Infection, 2002
- Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital.Journal of Antimicrobial Chemotherapy, 2001
- Reemergence of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus in France: a Phylogenetic ApproachJournal of Clinical Microbiology, 2001
- Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitalsJournal of Antimicrobial Chemotherapy, 2001
- Antibiotic susceptibility and genotypic characterization of methicillin-resistant Staphylococcus aureus strains in eastern FranceJournal of Hospital Infection, 2000
- Contrôle des infections à Staphylococcus aureus méticillinorésistant dans un CHU : Analyse critique des résultats obtenusMedecine Et Maladies Infectieuses, 1999
- Application of the ATC/DDD methodology to monitor antibiotic drug useEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- eemergence of Gentamicin‐Susceptible Strains of Methicillin‐ResistantStaphylococcus aureus: Roles of an Infection Control Program and Changes in Aminoglycoside Use RClinical Infectious Diseases, 1997
- Balancing the drug-resistance equationTrends in Microbiology, 1994
- Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus in the United StatesInfection Control & Hospital Epidemiology, 1990